KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Johnson & Johnson (JNJ) EPS (Weighted Average and Diluted) (2016 - 2025)

Johnson & Johnson (JNJ) has disclosed EPS (Weighted Average and Diluted) for 17 consecutive years, with $2.09 as the latest value for Q4 2025.

  • Quarterly EPS (Weighted Average and Diluted) rose 48.23% to $2.09 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $11.04 through Dec 2025, up 90.67% year-over-year, with the annual reading at $11.03 for FY2025, 90.5% up from the prior year.
  • EPS (Weighted Average and Diluted) hit $2.09 in Q4 2025 for Johnson & Johnson, down from $2.12 in the prior quarter.
  • In the past five years, EPS (Weighted Average and Diluted) ranged from a high of $10.21 in Q4 2023 to a low of -$0.19 in Q2 2023.
  • Historically, EPS (Weighted Average and Diluted) has averaged $2.17 across 5 years, with a median of $1.69 in 2022.
  • Biggest five-year swings in EPS (Weighted Average and Diluted): crashed 111.11% in 2023 and later soared 805.26% in 2024.
  • Year by year, EPS (Weighted Average and Diluted) stood at $1.37 in 2021, then grew by 18.25% to $1.62 in 2022, then increased by 3.09% to $1.67 in 2023, then fell by 15.57% to $1.41 in 2024, then surged by 48.23% to $2.09 in 2025.
  • Business Quant data shows EPS (Weighted Average and Diluted) for JNJ at $2.09 in Q4 2025, $2.12 in Q3 2025, and $2.29 in Q2 2025.